| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.085 | 0.06 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.054 | 0.07 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |